The dopamine D3 receptor antagonist nafadotride inhibits development of locomotor sensitization to amphetamine

2000 ◽  
Vol 867 (1-2) ◽  
pp. 239-242 ◽  
Author(s):  
Neil M Richtand ◽  
Aaron D Logue ◽  
Jeffrey A Welge ◽  
John Perdiue ◽  
Lamont J Tubbs ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Locomotor Sensitization ◽  
Dopamine D3 Receptor ◽  
D3 Receptor ◽  
Dopamine D3

scholarly journals Effects of the selective dopamine D3 receptor antagonist PG01037 on morphine-induced hyperactivity and antinociception in mice

2021 ◽  
pp. 113506
Author(s):  
Christian A. Botz-Zapp ◽  
Stephanie L. Foster ◽  
Desta M. Pulley ◽  
Briana Hempel ◽  
Guo-Hua Bi ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Dopamine D3 Receptor ◽  
D3 Receptor ◽  
Dopamine D3 ◽  
Selective Dopamine

scholarly journals Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs

2018 ◽  
Vol 8 (1) ◽  
Author(s):  
Noelia Ferruz ◽  
Stefan Doerr ◽  
Michelle A. Vanase-Frawley ◽  
Yaozhong Zou ◽  
Xiaomin Chen ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Dopamine D3 Receptor ◽  
D3 Receptor ◽  
Dopamine D3

A Double-Blind, Randomized, Placebo-Controlled Study of the Dopamine D3 Receptor Antagonist ABT-925 in Patients With Acute Schizophrenia

2011 ◽  
Vol 31 (2) ◽  
pp. 221-225 ◽  
Author(s):  
Laura Redden ◽  
Beatrice Rendenbach-Mueller ◽  
Walid M. Abi-Saab ◽  
David A. Katz ◽  
Armen Goenjian ◽  
...  
Keyword(s):  
Receptor Antagonist ◽  
Controlled Study ◽  
Dopamine D3 Receptor ◽  
D3 Receptor ◽  
Double Blind ◽  
Acute Schizophrenia ◽  
Dopamine D3
Sign in / Sign up

Export Citation Format

Share Document